Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilates training plus silymarin for non-alcoholic fatty liver disease
IRCT20230216057435N1Phase 3Completed
- Sponsor
- Shahid Chamran University of Ahvaz
- Start
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of silymarin in metabolic dysfunction-associated steatotic liver disease (MASLD), sponsored by Shahid Chamran University of Ahvaz. Started Apr 2022; status: completed.
02
Drugs
silymarin
03
Conditions
metabolic dysfunction-associated steatotic liver disease (MASLD)
Beyond the preview
Go deeper on IRCT20230216057435N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230216057435N1.